Avidity Partners Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-166,000
Closed -$11.6M 92
2024
Q1
$11.6M Buy
+166,000
New +$11.6M 0.38% 65
2023
Q2
Sell
-252,000
Closed -$8.87M 100
2023
Q1
$8.87M Sell
252,000
-168,700
-40% -$5.94M 0.29% 66
2022
Q4
$19.3M Buy
420,700
+85,700
+26% +$3.93M 0.42% 51
2022
Q3
$16.2M Buy
+335,000
New +$16.2M 0.33% 57